Clinical trialNCT01211847CompletedPhase 2Interventional

Efficacy Study of Diazoxide Choline to Treat Hypertriglyceridemia

SponsorEssentialis, Inc.Enrollment44DyslipidemiaHypertriglyceridemia

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Once a day oral administration with DCCR helps lower triglycerides

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

Alain Baron, M.D.
Essentialis, Inc.
Study Director
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

No facility list is in our current data snapshot for this study. The registry record on ClinicalTrials.gov ↗ carries any published locations. Why? →

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Diazoxide Choline Controlled-Release TabletPlacebo

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 31 Oct 2010
Primary completion: 30 Sept 2011
Completion: 31 Dec 2011
Last update posted: 10 Jan 2014
Registered enrollment: 44
Registry id: NCT01211847

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 11 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.